Source: PHARMACEUTICAL BUSINESS REVIEW

iCeutica: iCeutica receives key patent for soluMatrix fine particle technology platform

iCeutica has announced that its wholly owned subsidiary has been awarded a key patent for its SoluMatrix Fine Particle Technology platform by the US Patent and Trademark Office (USPTO).

Read full article »
iCeutica's Competitors | iCeutica's News | iCeutica's Financials
Stay up-to-date with the latest news on iCeutica
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Matthew Callahan's photo - President & CEO of iCeutica

President & CEO

Matthew Callahan

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on iCeutica